The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery
Open accessAbstract
BACKGROUND: Postoperative progression and chemotherapy resistance is the major cause of treatment failure in patients with triple-negative breast cancer (TNBC). Currently, there is a lack of an ideal predictive model for the progression and drug sensitivity of postoperative TNBC patients. Diverse programmed cell death (PCD) patterns play an important role in tumor progression, which has the potential to be a prognostic and drug sensitivity indicator for TNBC after surgery. MATERIALS AND METHODS: Twelve PCD patterns (apoptosis, necroptosis, pyroptosis, ferroptosis, cuproptosis, entotic cell death, netotic cell death, parthanatos, lysosome-dependent cell death, autophagy-dependent cell death, alkaliptosis, and oxeiptosis) were analyzed for model construction. Bulk transcriptome, single-cell transcriptome, genomics, and clinical information were collected from TCGA-BRCA, METABRIC, GSE58812, GSE21653, GSE176078, GSE75688, and KM-plotter cohorts to validate the model. RESULTS: The machine learning algorithm established a cell death index (CDI) with a 12-gene signature. Validated in five independent datasets, TNBC patients with high CDI had a worse prognosis after surgery. Two molecular subtypes of TNBC with distinct vital biological processes were identified by an unsupervised clustering model. A nomogram with high predictive performance was constructed by incorporating CDI with clinical features. Furthermore, CDI was associated with immune checkpoint genes and key tumor microenvironment components by integrated analysis of bulk and single-cell transcriptome. TNBC patients with high CDI are resistant to standard adjuvant chemotherapy regimens (docetaxel, oxaliplatin, etc.); however, they might be sensitive to palbociclib (an FDA-approved drug for luminal breast cancer). CONCLUSION: Generally, we established a novel CDI model by comprehensively analyzing diverse cell death patterns, which can accurately predict clinical prognosis and drug sensitivity of TNBC after surgery. A user-friendly website was created to facilitate the application of this prediction model (https://tnbc.shinyapps.io/CDI_Model/).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
Integrated analysis of multimodal single-cell data
Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W. M., Zheng, S., Butler, A., Lee, M. J., Wilk, A. J., Darby, C., Zagar, M., et al. (2020) · doi:10.1101/2020.10.12.335331 · Cited by 15,508
Self-citationGSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440
Robust enumeration of cell subsets from tissue expression profiles
Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn, M., & Alizadeh, A. A. (2015) · Nature Methods · doi:10.1038/nmeth.3337 · Cited by 13,224
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Self-citationConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Wilkerson, M. D., & Hayes, D. N. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq170 · Cited by 5,669
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Mayakonda, A., Lin, D.-C., Assenov, Y., Plass, C., & Koeffler, H. P. (2018) · Genome Research · doi:10.1101/gr.239244.118 · Cited by 4,935
Copper induces cell death by targeting lipoylated TCA cycle proteins
Tsvetkov, P., Coy, S., Petrova, B., Dreishpoon, M., Verma, A., Abdusamad, M., Rossen, J., Joesch-Cohen, L., Humeidi, R., Spangler, R. D., et al. (2022) · Science · doi:10.1126/science.abf0529 · Cited by 4,932
circlize implements and enhances circular visualization in R
Gu, Z., Gu, L., Eils, R., Schlesner, M., & Brors, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu393 · Cited by 4,246
The molecular machinery of regulated cell death
Tang, D., Kang, R., Berghe, T. V., Vandenabeele, P., & Kroemer, G. (2019) · Cell Research · doi:10.1038/s41422-019-0164-5 · Cited by 2,549
Targeting apoptosis in cancer therapy
Carneiro, B. A., & El-Deiry, W. S. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0341-y · Cited by 2,542
Blanche, P., Dartigues, J., & Jacqmin‐Gadda, H. (2013) · Statistics in Medicine · doi:10.1002/sim.5958 · Cited by 1,852
Maeser, D., Gruener, R. F., & Huang, R. S. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab260 · Cited by 1,791
A single-cell and spatially resolved atlas of human breast cancers
Wu, S. Z., Al-Eryani, G., Roden, D. L., Junankar, S., Harvey, K., Andersson, A., Thennavan, A., Wang, C., Torpy, J. R., Bartonicek, N., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00911-1 · Cited by 1,775
Gasdermin E suppresses tumour growth by activating anti-tumour immunity
Zhang, Z., Zhang, Y., Xia, S., Kong, Q., Li, S., Liu, X., Junqueira, C., Meza-Sosa, K. F., Mok, T. M. Y., Ansara, J., et al. (2020) · Nature · doi:10.1038/s41586-020-2071-9 · Cited by 1,686
Self-citationFerroptosis, necroptosis, and pyroptosis in anticancer immunity
Tang, R., Xu, J., Zhang, B., Liu, J., Liang, C., Hua, J., Meng, Q., Yu, X., & Shi, S. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00946-7 · Cited by 1,273
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Manguso, R. T., Pope, H. W., Zimmer, M. D., Brown, F. D., Yates, K. B., Miller, B. C., Collins, N. B., Bi, K., LaFleur, M. W., Juneja, V. R., et al. (2017) · Nature · doi:10.1038/nature23270 · Cited by 1,147
Large-scale public data reuse to model immunotherapy response and resistance
Fu, J., Li, K., Zhang, W., Wan, C., Zhang, J., Jiang, P., & Liu, X. S. (2020) · Genome Medicine · doi:10.1186/s13073-020-0721-z · Cited by 1,067
Apoptosis, autophagy, necroptosis, and cancer metastasis
Su, Z., Yang, Z., Xu, Y., Chen, Y., & Yu, Q. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0321-5 · Cited by 1,042
Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
Chung, W., Eum, H. H., Lee, H.-O., Lee, K.-M., Lee, H.-B., Kim, K.-T., Ryu, H. S., Kim, S., Lee, J. E., Park, Y. H., et al. (2017) · Nature Communications · doi:10.1038/ncomms15081 · Cited by 992
Targeting Autophagy in Cancer: Recent Advances and Future Directions
Amaravadi, R. K., Kimmelman, A. C., & Debnath, J. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0292 · Cited by 928
Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology
Sturm, G., Finotello, F., Petitprez, F., Zhang, J. D., Baumbach, J., Fridman, W. H., List, M., & Aneichyk, T. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz363 · Cited by 928
Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study
Heer, E., Harper, A., Escandor, N., Sung, H., McCormack, V., & Fidler-Benaoudia, M. M. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30215-1 · Cited by 888
Triple-negative breast cancer: disease entity or title of convenience?
Carey, L., Winer, E., Viale, G., Cameron, D., & Gianni, L. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.154 · Cited by 783
Lysosomal cell death at a glance
Aits, S., & Jäättelä, M. (2013) · Journal of Cell Science · doi:10.1242/jcs.091181 · Cited by 667
Metabolic Regulation of Macrophage Polarization in Cancer
Mehla, K., & Singh, P. K. (2019) · Trends in Cancer · doi:10.1016/j.trecan.2019.10.007 · Cited by 617
Parthanatos: mitochondrial‐linked mechanisms and therapeutic opportunities
Fatokun, A. A., Dawson, V. L., & Dawson, T. M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12416 · Cited by 594
STRUCTURE, FUNCTION AND REGULATION OF THE VACUOLAR (H+)-ATPase
Stevens, T. H., & Forgac, M. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.779 · Cited by 588
TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis
Jiang, Z., Lim, S.-O., Yan, M., Hsu, J. L., Yao, J., Wei, Y., Chang, S.-S., Yamaguchi, H., Lee, H.-H., Ke, B., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci139434 · Cited by 325
Targeting autophagy-related protein kinases for potential therapeutic purpose
Xiang, H., Zhang, J., Lin, C., Zhang, L., Liu, B., & Ouyang, L. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.10.003 · Cited by 246
JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice
Song, X., Zhu, S., Xie, Y., Liu, J., Sun, L., Zeng, D., Wang, P., Ma, X., Kroemer, G., Bartlett, D. L., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.12.004 · Cited by 245
Zou, Y., Zheng, S., Xie, X., Ye, F., Hu, X., Tian, Z., Yan, S.-M., Yang, L., Kong, Y., Tang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30217-7 · Cited by 226
Self-citationWen, S., Niu, Y., Lee, S. O., & Chang, C. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.07.008 · Cited by 159
Li, L., Zhu, Z., Zhao, Y., Zhang, Q., Wu, X., Miao, B., Cao, J., & Fei, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-43924-x · Cited by 159
Zou, Y., Zou, X., Zheng, S., Tang, H., Zhang, L., Liu, P., & Xie, X. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920940928 · Cited by 136
Self-citationThe Role of Circular RNA CDR1as/ciRS-7 in Regulating Tumor Microenvironment: A Pan-Cancer Analysis
Zou, Y., Zheng, S., Deng, X., Yang, A., Xie, X., Tang, H., & Xie, X. (2019) · Biomolecules · doi:10.3390/biom9090429 · Cited by 129
Self-citationOxeiptosis: a discreet way to respond to radicals
Scaturro, P., & Pichlmair, A. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.10.006 · Cited by 115
Zheng, S., Zou, Y., Liang, J., Xiao, W., Yang, A., Meng, T., Lu, S., Luo, Z.-B., & Xie, X. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12747 · Cited by 100
Self-citationZou, Y., Hu, X., Zheng, S., Yang, A., Li, X., Tang, H., Kong, Y., & Xie, X. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103137 · Cited by 97
Self-citationHSPA5 negatively regulates lysosomal activity through ubiquitination of MUL1 in head and neck cancer
Kim, S., Kim, H. J., Kim, H., Kim, D. H., Han, J. H., Byeon, H. K., Lee, K., & Kim, C. (2017) · Autophagy · doi:10.1080/15548627.2017.1414126 · Cited by 82
Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer
Nagelkerke, A., Mujčić, H., Bussink, J., Wouters, B. G., van Laarhoven, H. W. M., Sweep, F. C. G. J., & Span, P. N. (2011) · Cancer · doi:10.1002/cncr.25938 · Cited by 78
Zhao, R., Kaakati, R. N., Lee, A. K., Liu, X., Li, F., & Li, C. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9736-y · Cited by 71
Zheng, S., Zou, Y., Xie, X., Liang, J., Yang, A., Yu, K., Wang, J., Tang, H., & Xie, X. (2020) · International Journal of Cancer · doi:10.1002/ijc.33009 · Cited by 68
Self-citationTargeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer
Hiraki, M., Maeda, T., Mehrotra, N., Jin, C., Alam, M., Bouillez, A., Hata, T., Tagde, A., Keating, A. E., Kharbanda, S. M., et al. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-018-0013-x · Cited by 66
Huang, P. F., Ouyang, D., Chang, S., Li, M., Li, L., Li, Q.-Y., Zeng, R., Zou, Q., Su, J., Zhao, P., et al. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0304-4 · Cited by 54
Nucleolar repression facilitates initiation and maintenance of senescence
Yang, L., Song, T., Chen, L., Soliman, H. H., & Chen, J. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1100777 · Cited by 46
Kim, J., Yu, D., Kwon, Y., Lee, K. S., Sim, S. H., Kong, S., Lee, E. S., Park, I. H., & Park, C. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0453 · Cited by 44
Xie, J., Tian, W., Tang, Y., Zou, Y., Zheng, S., Wu, L., Zeng, Y., Wu, S., Xie, X., & Xie, X. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.834593 · Cited by 44
Self-citationArif, T., Amsalem, Z., & Shoshan‐Barmatz, V. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.05.003 · Cited by 43
The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer
Johnson, R., Sabnis, N. A., McConathy, W. J., & Lacko, A. G. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5020353 · Cited by 36
Ohashi, R., Angori, S., Batavia, A. A., Rupp, N. J., Ajioka, Y., Schraml, P., & Moch, H. (2020) · Cancers · doi:10.3390/cancers12020465 · Cited by 30
Mahdavi, R., Yousefpour, N., Abbasvandi, F., Ataee, H., Hoseinpour, P., Akbari, M. E., Parniani, M., Delshad, B., Avatefi, M., Nourinejad, Z., et al. (2021) · International Journal of Surgery · doi:10.1016/j.ijsu.2021.106166 · Cited by 29
Yao, N., Li, W., Liu, T., Siyin, S. T., Chen, X., Wang, W., Duan, N., Chen, Y., & Qu, J. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.08.056 · Cited by 12
Bolliger, M. J., Lanmüeller, P., Schuetz, M., Heilig, B., Windischbauer, A., Jakesz, R., Zehetgruber, T., Gnant, M., Gleiß, A., Dörfler, D., et al. (2022) · International Journal of Surgery · doi:10.1016/j.ijsu.2022.106694 · Cited by 12
Pan, Y., Abdureyim, M., Yao, Q., & Li, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.604038 · Cited by 9
Cited by
Breast cancer: pathogenesis and treatments
Xiong, X., Zheng, L.-W., Ding, Y., Chen, Y.-F., Cai, Y.-W., Wang, L.-P., Huang, L., Liu, C.-C., Shao, Z.-M., & Yu, K.-D. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02108-4 · Cited by 958
Zou, Y., Ye, F., Kong, Y., Hu, X., Deng, X., Xie, J., Song, C., Ou, X., Wu, S., Wu, L., et al. (2023) · Advanced Science · doi:10.1002/advs.202203699 · Cited by 278
Self-citation
Metadata
- Authors
- Zou, Y., Xie, J., Zheng, S., Liu, W., Tang, Y., Tian, W., Deng, X., Wu, L., Zhang, Y., Wong, C.-W., Tan, D., Liu, Q., & Xie, X.
- Venue
- International Journal of Surgery
- Published
- 2022-11
- Volume
- 107
- Pages
- 106936
- ISSN
- 1743-9159 (ISSN-L)
- 1743-9191
- OpenAlex
- W4296445148
- Cited by
- 426
- References
- 59
- FWCI
- 32.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.